# Uroxatral

NDC: 59212-200
Generic name: Alfuzosin HCl
Labeler / Manufacturer: Advanz Pharma (US) Corp.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20130603

FDA application: NDA021287

## Active ingredients

- ALFUZOSIN HYDROCHLORIDE: 10 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"59212-200"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=59212-200
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9fc7f119-f36b-44cf-945d-940160f3afe3
